These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 6397984)

  • 21. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries.
    Cohen RA; Shepherd JT; Vanhoutte PM
    Am J Physiol; 1983 Dec; 245(6):H1077-80. PubMed ID: 6660308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptors mediating the effects of 5-hydroxytryptamine on the tracheal vasculature and smooth muscle of sheep.
    Webber SE; Salonen RO; Widdicombe JG
    Br J Pharmacol; 1990 Jan; 99(1):21-6. PubMed ID: 2331572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin and the blood vessel wall.
    Vanhoutte PM; Lüscher TF
    J Hypertens Suppl; 1986 Apr; 4(1):S29-35. PubMed ID: 2939211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular effects of serotonin and ischemia.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S15-9. PubMed ID: 1369711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [2-(omega-phenylalkyl)phenoxy]alkylamines.II: Synthesis and selective serotonin-2 receptor binding.
    Tanaka N; Goto R; Ito R; Hayakawa M; Sugidachi A; Ogawa T; Asai F; Fujimoto K
    Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):245-55. PubMed ID: 10705513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):301-3. PubMed ID: 3157065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs.
    Verheggen R; Freudenthaler S; Meyer-Dulheuer F; Kaumann AJ
    Br J Pharmacol; 1996 Jan; 117(2):283-92. PubMed ID: 8789380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A paradox: the 5-HT2-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf. Allosteric regulation of 5-HT2-receptors.
    Kaumann AJ; Frenken M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):295-300. PubMed ID: 3157064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors.
    Saxena PR; Lawang A
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):235-52. PubMed ID: 2933009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolongation of rat tail bleeding time by ketanserin: mechanisms of action.
    Buczko W; Gambino MC; De Gaetano G
    Eur J Pharmacol; 1984 Aug; 103(3-4):261-8. PubMed ID: 6237923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonergic agonists stimulate inositol lipid metabolism in rabbit platelets.
    Schächter M; Godfrey PP; Minchin MC; McClue SJ; Young MM
    Life Sci; 1985 Oct; 37(17):1641-7. PubMed ID: 2997568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for functional 5-HT2 receptor sites on human blood platelets.
    De Clerck F; Xhonneux B; Leysen J; Janssen PA
    Biochem Pharmacol; 1984 Sep; 33(17):2807-11. PubMed ID: 6466388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E; Markwardt F
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin, 5-HT2 receptors, and their blockade by naftidrofuryl: a targeted therapy of vascular diseases.
    Wiernsperger NF
    J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S37-43. PubMed ID: 7517475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Hydroxytryptamine contracts human uterine artery smooth muscle predominantly via 5-HT2 receptors.
    Karlsson C; Bodelsson G; Bodelsson M; Stjernquist M
    Hum Reprod; 1997 Feb; 12(2):361-7. PubMed ID: 9070726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery.
    Müller-Schweinitzer E; Engel G
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):287-92. PubMed ID: 6664382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
    Cohen RA
    J Pharmacol Exp Ther; 1986 May; 237(2):548-52. PubMed ID: 2939235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets.
    Cohen RA; Shepherd JT; Vanhoutte PM
    Science; 1983 Jul; 221(4607):273-4. PubMed ID: 6574604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for two populations of 5-hydroxytryptamine receptors in dog basilar artery.
    Frenken M
    J Pharmacol Exp Ther; 1989 Jul; 250(1):379-87. PubMed ID: 2545865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by ketanserin of serotonin induced cerebral arteriolar constriction.
    Thompson JA; Wei EP; Kontos HA
    Stroke; 1984; 15(6):1021-4. PubMed ID: 6506113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.